VIA
JNCE

Vident Investment Advisory’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Vident Investment Advisory’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-133,825
Closed -$2.75M – 990
2018
Q1 		$2.75M Buy
133,825
+36,359
+37% +$746K 0.11% 263
2017
Q4 		$1.24M Buy
97,466
+26,628
+38% +$340K 0.06% 343
2017
Q3 		$1.1M Buy
70,838
+2,146
+3% +$33.4K 0.06% 354
2017
Q2 		$964K Buy
+68,692
New +$964K 0.08% 318